Join the Oncology Voice Network. Join for Free
Top 5 MSL Frustrations and How to Overcome Them
Medical Science Liaisons Key Opinion Leaders time management communication skills impostor syndrome

Top 5 MSL Frustrations and How to Overcome Them


Share This Article


Summary

In this episode, Tom Caravela and guests Sarah Snyder and Patrina Pellett discuss the common frustrations faced by Medical Science Liaisons, exploring the top challenges and offering practical solutions. The panelists delve into frustrations such as access to KOLs, information overload, role clarity, and impostor syndrome, with an additional focus on time management and communication challenges. They offer strategies to overcome these hurdles, emphasizing the importance of addressing self-doubt. The episode concludes with communication and time management tips.

Key Points

  • Building strong relationships and leveraging internal networks are key strategies for overcoming challenges in gaining access to Key Opinion Leaders (KOLs).
  • Effective time management and setting aside personal time are crucial for preventing burnout and maintaining a healthy work-life balance as an MSL.
  • Confidence in communication and avoiding data dumping are essential skills for MSLs to master in order to effectively present information and engage with healthcare professionals.

Click for Source
Medical Science Liaisons, Key Opinion Leaders, time management, communication skills, impostor syndrome

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
OVN Avatar Kelvin Chan, Seungree Nam, Bill Evans, Claire de Oliveira Alexandra Chambers, Scott Gavura, Jeffrey Hoch, Rebecca E Mercer, Wei Fang Dai, Jaclyn Beca, Mina Tadrous, Wanrudee Isaranuwatchai

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration

Article
Outcome measures for oncology alternative payment models: practical considerations and recommendations
OVN Avatar Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD

Outcome measures for oncology alternative payment models: practical considerations and recommendations

Explore OVN